Literature DB >> 20678503

The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases.

John R Finnerty1, Wang-Xia Wang, Sébastien S Hébert, Bernard R Wilfred, Guogen Mao, Peter T Nelson.   

Abstract

The miR-15/107 group of microRNA (miRNA) gene is increasingly appreciated to serve key functions in humans. These miRNAs regulate gene expression involved in cell division, metabolism, stress response, and angiogenesis in vertebrate species. The miR-15/107 group has also been implicated in human cancers, cardiovascular disease and neurodegenerative disease, including Alzheimer's disease. Here we provide an overview of the following: (1) the evolution of miR-15/107 group member genes; (2) the expression levels of miRNAs in mammalian tissues; (3) evidence for overlapping gene-regulatory functions by different miRNAs; (4) the normal biochemical pathways regulated by miR-15/107 group miRNAs; and (5) the roles played by these miRNAs in human diseases. Membership in this group is defined based on sequence similarity near the mature miRNAs' 5' end: all include the sequence AGCAGC. Phylogeny of this group of miRNAs is incomplete; thus, a definitive taxonomic classification (e.g., designation as a "superfamily") is currently not possible. While all vertebrates studied to date express miR-15a, miR-15b, miR-16, miR-103, and miR-107, mammals alone are known to express miR-195, miR-424, miR-497, miR-503, and miR-646. Multiple different miRNAs in the miR-15/107 group are expressed at moderate to high levels in human tissues. We present data on the expression of all known miR-15/107 group members in human cerebral cortical gray matter and white matter using new miRNA profiling microarrays. There is extensive overlap in the mRNAs targeted by miR-15/107 group members. We show new data from cultured H4 cancer cells that demonstrate similarities in mRNAs targeted by miR-16 and miR-103 and also support the importance of the mature miRNAs' 5' seed region in mRNA target recognition. In conclusion, the miR-15/107 group of miRNA genes is a fascinating topic of study for evolutionary biologists, miRNA biochemists, and clinically oriented translational researchers alike.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20678503      PMCID: PMC2978331          DOI: 10.1016/j.jmb.2010.07.051

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  191 in total

Review 1.  Interpretation and applicability of microRNA data to the context of Alzheimer's and age-related diseases.

Authors:  Patrick Provost
Journal:  Aging (Albany NY)       Date:  2010-03-31       Impact factor: 5.682

2.  An optimized isolation and labeling platform for accurate microRNA expression profiling.

Authors:  Jaclyn Shingara; Kerri Keiger; Jeffrey Shelton; Walairat Laosinchai-Wolf; Patricia Powers; Richard Conrad; David Brown; Emmanuel Labourier
Journal:  RNA       Date:  2005-07-25       Impact factor: 4.942

Review 3.  New tricks for animal microRNAS: targeting of amino acid coding regions at conserved and nonconserved sites.

Authors:  Isidore Rigoutsos
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

4.  MicroRNA responses to cellular stress.

Authors:  Carmen J Marsit; Karen Eddy; Karl T Kelsey
Journal:  Cancer Res       Date:  2006-11-15       Impact factor: 12.701

5.  miR-15a and miR-16-1 down-regulation in pituitary adenomas.

Authors:  Arianna Bottoni; Daniela Piccin; Federico Tagliati; Andrea Luchin; Maria Chiara Zatelli; Ettore C degli Uberti
Journal:  J Cell Physiol       Date:  2005-07       Impact factor: 6.384

6.  A novel microRNA and transcription factor mediated regulatory network in schizophrenia.

Authors:  An-Yuan Guo; Jingchun Sun; Peilin Jia; Zhongming Zhao
Journal:  BMC Syst Biol       Date:  2010-02-15

7.  MicroRNAs differentially expressed in ACTH-secreting pituitary tumors.

Authors:  Fernando Colbari Amaral; Natalia Torres; Fabiano Saggioro; Luciano Neder; Hélio Rubens Machado; Wilson Araújo Silva; Ayrton Custódio Moreira; Margaret Castro
Journal:  J Clin Endocrinol Metab       Date:  2008-10-07       Impact factor: 5.958

8.  The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.

Authors:  Ulf Klein; Marie Lia; Marta Crespo; Rachael Siegel; Qiong Shen; Tongwei Mo; Alberto Ambesi-Impiombato; Andrea Califano; Anna Migliazza; Govind Bhagat; Riccardo Dalla-Favera
Journal:  Cancer Cell       Date:  2010-01-07       Impact factor: 31.743

9.  Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues.

Authors:  Heidi J Peltier; Gary J Latham
Journal:  RNA       Date:  2008-03-28       Impact factor: 4.942

Review 10.  Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways.

Authors:  Bernard R Wilfred; Wang-Xia Wang; Peter T Nelson
Journal:  Mol Genet Metab       Date:  2007-05-22       Impact factor: 4.797

View more
  175 in total

1.  Identification of microRNAs that mediate thyroid cell growth induced by TSH.

Authors:  Takeshi Akama; Mariko Sue; Akira Kawashima; Huhehasi Wu; Kazunari Tanigawa; Sayuri Suzuki; Moyuru Hayashi; Aya Yoshihara; Yuko Ishido; Norihisa Ishii; Koichi Suzuki
Journal:  Mol Endocrinol       Date:  2012-02-02

2.  Human CYP2C8 is post-transcriptionally regulated by microRNAs 103 and 107 in human liver.

Authors:  Shu-Yun Zhang; Sailesh Surapureddi; Sherry Coulter; Stephen S Ferguson; Joyce A Goldstein
Journal:  Mol Pharmacol       Date:  2012-06-20       Impact factor: 4.436

Review 3.  Noncoding RNAs and pancreatic cancer.

Authors:  Juan-Fei Peng; Yan-Yan Zhuang; Feng-Ting Huang; Shi-Neng Zhang
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

Review 4.  Expression patterns of placental microRNAs.

Authors:  Jean-Francois Mouillet; Tianjiao Chu; Yoel Sadovsky
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-03-21

5.  Constructing and characterizing a bioactive small molecule and microRNA association network for Alzheimer's disease.

Authors:  Fanlin Meng; Enyu Dai; Xuexin Yu; Yan Zhang; Xiaowen Chen; Xinyi Liu; Shuyuan Wang; Lihua Wang; Wei Jiang
Journal:  J R Soc Interface       Date:  2013-12-18       Impact factor: 4.118

6.  The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration.

Authors:  Silvia Moncini; Alessandro Salvi; Paola Zuccotti; Gabriella Viero; Alessandro Quattrone; Sergio Barlati; Giuseppina De Petro; Marco Venturin; Paola Riva
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

7.  The microRNA 424/503 cluster reduces CDC25A expression during cell cycle arrest imposed by transforming growth factor β in mammary epithelial cells.

Authors:  David Llobet-Navas; Ruth Rodriguez-Barrueco; Janis de la Iglesia-Vicente; Mireia Olivan; Veronica Castro; Laura Saucedo-Cuevas; Netonia Marshall; Preeti Putcha; Mireia Castillo-Martin; Evan Bardot; Elena Ezhkova; Antonio Iavarone; Carlos Cordon-Cardo; Jose M Silva
Journal:  Mol Cell Biol       Date:  2014-09-29       Impact factor: 4.272

8.  Profile of circulating microRNAs in fibromyalgia and their relation to symptom severity: an exploratory study.

Authors:  Jan L Bjersing; Maria I Bokarewa; Kaisa Mannerkorpi
Journal:  Rheumatol Int       Date:  2014-09-28       Impact factor: 2.631

9.  Integrated miRNA and mRNA expression profiling of tension force-induced bone formation in periodontal ligament cells.

Authors:  Maolin Chang; Heng Lin; Meng Luo; Jie Wang; Guangli Han
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-06-20       Impact factor: 2.416

Review 10.  The role of miRNAs in cardiovascular disease risk factors.

Authors:  Joy N Jones Buie; Andrew J Goodwin; James A Cook; Perry V Halushka; Hongkuan Fan
Journal:  Atherosclerosis       Date:  2016-09-22       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.